- For intravenous use only and is indicated for the short-term treatment of patients with cardiac decompensation due to depressed heart contractility
Uses:
- Indicated for the short-term treatment of patients with cardiac decompensation due to depressed heart contractility, either from organic heart disease or cardiac surgical procedures
- Used to provide inotropic support when parenteral (intravenous) therapy is necessary
Features:
- Dobutamine stimulates heart muscle and improves blood flow by helping the heart pump better
- It is a 500mg dose in 250mL of 5% Dextrose, resulting in a concentration of 2000mcg/mL
- For intravenous use only
- Indicated for the short-term treatment of patients with cardiac decompensation due to depressed heart contractility
- Administered as a continuous intravenous infusion using a calibrated electronic infusion device
- Infusion rates vary, typically from 2-20mcg/kg/min
- Container system may not be suitable for pediatric patients under 30kg
- Continuous monitoring of vital signs and cardiac function is recommended during administration
